Cyclica is a trailblazer in the field of drug discovery, leveraging the power of artificial intelligence and computational biophysics to transform the way we develop new medicines. Their integrated, AI-augmented drug discovery platform is designed to evaluate and design drug candidates with favorable polypharmacological profiles and medicinal properties.

The platform is powered by two machine learning engines, MatchMaker and POEM, which enable multi-objective evaluation and design of drug candidates. This approach not only enhances the safety and efficacy of drugs but also significantly reduces attrition rates and timelines to the clinic.